OP-130: USE OF POINT-OF-CARE TESTING TO ASSESS OPTIMAL ANTIPLATELET THERAPY WHEN A NASOGASTRIC TUBE IS THE ONLY WAY OF ADMINISTRATION
2011
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI